DarioHealth
DarioHealth is a digital therapeutics company offering a multi-condition digital health platform for chronic disease management — covering cardiometabolic, musculoskeletal, and behavioral health — serving self-insured employers, health plans, pharmaceutical companies, and individual consumers via connected devices and the DarioIQ AI platform.
- Company typePublic
- Founded2011
- HeadquartersNew York, United States
- Headcount101–250
- GTM typeB2B and B2C
- OfferingSoftware
What DarioHealth does
DarioHealth is a digital therapeutics company founded in 2011 and publicly traded on NASDAQ under the ticker DRIO, headquartered in New York with 101–250 employees. The company operates a multi-condition digital health platform addressing cardiometabolic (diabetes, hypertension, weight management), musculoskeletal (posture, pain, injury), and behavioral health (anxiety, depression, stress) conditions through a single integrated app and ecosystem of FDA-cleared connected devices (glucometer, blood pressure monitor, weighing scale). The platform's core technical layer is DarioIQ, a proprietary AI combining Advisor, Sentinel, and Strategist components trained on over 13 billion real-world data points, with a multi-phase GenAI roadmap. An Oral GLP-1 digital health solution launched in March 2026 extends the platform into medication adherence support, and the company has integrated capabilities from acquired entities Twill (behavioral health, acquired Feb 2024 for $10M) and Physimax (AI-powered MSK screening, acquired Jan 2022).
DarioHealth generates revenue through three primary streams: (1) B2B subscription contracts with self-insured employers and health plans, with milestone-based pricing tied to clinical outcomes and engagement; (2) direct-to-consumer sales of devices, test strips, and individual memberships through its mobile app on iOS and Android; and (3) pharmaceutical industry partnerships and licensing arrangements, including a $30M agreement with Sanofi for digital companion solutions. Distribution occurs through direct enterprise sales, consultant partnerships, a channel partner ecosystem anchored by Solera Health and Amwell (providing access to 116M+ covered lives with potential expansion to 175M+), and DTC app store channels.
The company reports strong customer-outcome metrics including 80% member retention after year one, 3.4–6X partner ROI, a 4.9/5 App Store rating, and clinically validated cost savings of $5,077 per user per year. In Q1 2026 revenue was $5.6M (second consecutive quarter of sequential growth from $5.2M in Q4 2025), operating expenses declined 21% YoY to $10.5M, and operating loss narrowed 22% YoY to $7.3M. The company holds approximately $20M in cash and in April 2026 the Board initiated a comprehensive strategic review with Perella Weinberg Partners as financial advisor following unsolicited inbound expressions of interest.
DarioHealth firmographics
Firmographics- Name
- DarioHealth
- Legal name
- DarioHealth Corp.
- Website
- https://dariohealth.com
- Company type
- Public
- Founded year
- 2011
- Headcount range
- 101–250 employees
- Short description
- DarioHealth is a digital therapeutics company offering a multi-condition digital health platform for chronic disease management — covering cardiometabolic, musculoskeletal, and behavioral health — serving self-insured employers, health plans, pharmaceutical companies, and individual consumers via connected devices and the DarioIQ AI platform.
- Ownership category
- akta.pro rank
DarioHealth industry classification
Industry- Product category
- Digital Therapeutics
- NAICS
- Diet and Weight Reducing Centers (812191)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)
Keywords
Where DarioHealth is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
DarioHealth business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- B2B Enterprise Sales (Employers & Health Plans): Subscription-based contracts with employers and health plans providing access to Dario's digital health platform for their members/employees. Uses milestone-based payment models linking costs to clinical progress and engagement outcomes.
- Direct-to-Consumer App & Device Sales: Direct consumer sales through mobile app (iOS/Android) and online store, including glucometer devices, test strips, and membership subscriptions for individual chronic condition management.
- Pharma Services & Partnerships: Partnerships with pharmaceutical companies (Sanofi collaboration mentioned) for digital therapeutics integration with drug therapies, creating bundled offerings to improve patient adherence and outcomes.
- Healthcare Cost Savings Studies: Value-based arrangements demonstrating cost savings ($5,077 medical cost savings per user per year) that support pricing and reimbursement negotiations with health plans and employers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise B2B platform access with per-employee/per-member pricing |
| Subscription | Monthly | Direct-to-consumer individual membership and device purchases |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels5 records
DarioHealth product offering
Product offeringCore offering
DarioHealth operates a multi-condition digital health platform addressing cardiometabolic (diabetes, hypertension, weight management), musculoskeletal, and behavioral health conditions through its mobile app combined with FDA-cleared connected devices (glucometer, blood pressure monitor, scale). The proprietary DarioIQ AI layer provides personalized guidance, biometric interpretation, and engagement optimization, supported by over 13 billion real-world data points and clinical evidence published in peer-reviewed journals.
Product overview
DarioHealth is a digital health company offering a multi-condition platform for chronic disease management. The core platform includes integrated solutions for Cardiometabolic (diabetes, hypertension, weight), Musculoskeletal (posture, pain, injury), and Behavioral Health (anxiety, depression, stress) conditions. The proprietary DarioIQ AI layer provides personalized guidance, real-time biometric interpretation, and engagement optimization. The company operates on a platform-plus-modules architecture with connected FDA-cleared devices, acquired capabilities from Twill (behavioral health) and Physimax (MSK screening), and offers specialized GLP-1 and Pharma Services modules. Target customers include employers, health plans, healthcare providers, and direct consumers.
Differentiator
Problem solved
Functional benefit
Products and services
- Cardiometabolic Solution Integrated solution for metabolic conditions including diabetes management, hypertension control, and weight management with evidence-based personalized approaches. Designed for employers, health plans, and individuals managing metabolic chronic conditions.
- Musculoskeletal Solution Digital solution for improving strength, mobility, and injury prevention covering posture correction, pain management, and injury recovery for musculoskeletal conditions. Delivered via mobile app and incorporates Physimax AI-powered screening technology.
- Behavioral Health Solution Digital behavioral health program providing quick connections to appropriate care for anxiety, depression, and stress management. Includes digital therapeutic content, live coaching, and crisis navigation capabilities from the Twill acquisition.
- GLP-1 Solution Digital health solution providing behavioral support to improve medication adherence and patient outcomes for oral GLP-1 treatments. Includes medication tracking, grocery scanning, and human coaching to optimize GLP-1 investments.
- Pharma Services Pharmaceutical industry partnership services enabling digital therapeutics integration with pharma drug offerings for improved patient adherence and outcomes. Includes digital companion apps, adherence support, and clinical trial integration.
- DarioIQ Proprietary AI layer integrated into the Dario Health app combining three components (Advisor, Sentinel, Strategist) to deliver personalized guidance, real-time biometric interpretation, and patient engagement. Built on over 13 billion real-world data points with demonstrated improvements of up to 40% in member retention and 57% in active sessions versus control.
- Dario Connected Devices FDA-cleared connected devices including a glucometer, blood pressure monitor, and weighing scale for real-time biometric tracking, sold directly through the Dario Store and paired with the Dario Health app.
Quantifiable outcome
- 80% member retention rate after year one
- +15 more outcomes
Companies that use DarioHealth
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
DarioHealth technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability6 records
Feature4 records
DarioHealth partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core, minor and major.
- Solera HealthcoreSolera Health expanded its digital health platform to include Dario's expanded hypertension program, more than doubling Dario's addressable market within the Solera network to more than 500,000 eligible lives. The expansion extends program reach into pre-hypertensive members through Stage 2 hypertension, tying revenue directly to engagement and clinical outcomes.
- John R. PalumbominorJohn R. Palumbo appointed to Board of Directors, bringing over 40 years of healthcare operating experience from Cencora and Veradigm. Expected to support DarioHealth's scaling efforts and transition from distribution model demonstration to efficient scaling.
- Twill (Acquired)majorDarioHealth completed a $10 million acquisition of Twill, a provider of digital chronic care solutions, to expand its healthcare platform. The deal included cash, shares, and additional funding, with anticipated increases in revenue and margins.
- Physimax Technologies Ltd. (Acquired)minorDarioHealth acquired Physimax Technologies Ltd., a provider of AI-powered musculoskeletal screening and injury risk assessment technology. The deal included stock, cash, and assumed liabilities to enhance Dario's digital therapeutics offerings.
- AmwellcoreAmwell serves as a blue-chip channel partner providing access to its telehealth ecosystem and covered lives, expanding DarioHealth's reach through the channel partner ecosystem.
- Sanofimajor$30 million agreement between Sanofi and DarioHealth for digital health platform collaboration, creating bundled drug-and-app offerings to improve patient adherence. Sanofi conducted research demonstrating $5,077 medical cost savings per Dario user.
Scale indicators18 records
Recent moves6 records
Expansion highlights6 records
DarioHealth competitors and assessment
Company assessmentDirect peers
- Omada Health: Multi-condition digital health platform addressing diabetes, hypertension, and musculoskeletal conditions for employers and health plans. Most direct competitor to DarioHealth given similar integrated care model, employer-focused GTM, and cardiometabolic emphasis.
- Virta Health: Digital health company specializing in diabetes reversal and metabolic health through nutrition and remote coaching. Direct competitor in the cardiometabolic space with similar employer/health plan go-to-market motion.
- Noom: Digital health platform addressing weight management, diabetes prevention, and broader cardiometabolic health through behavior change programs. Direct competitor in weight and cardiometabolic with similar employer and consumer channels.
- Hinge Health: Digital musculoskeletal health platform providing exercise therapy and AI-powered motion tracking for MSK conditions. Direct competitor in Dario's MSK solution line with similar employer-focused B2B distribution.
- Sword Health: Digital MSK care platform combining AI motion assessment with virtual physical therapy. Direct competitor in the MSK condition vertical with similar employer and health plan B2B distribution model.
- Welldoc: Digital health company focused on cardiometabolic conditions with FDA-cleared AI-powered platform for diabetes, hypertension, and heart failure. Direct competitor in connected care with similar health plan and pharma partnership models.
Broad incumbents
- Livongo (Teladoc Health): Pioneer in digital chronic condition management, now part of Teladoc Health. Competes across diabetes, hypertension, weight management, and behavioral health within a broader telehealth portfolio serving employers and health plans.
- Verily (Alphabet): Alphabet-owned health technology company with broader precision health portfolio including chronic condition management and research-grade health platforms. Large incumbent with deeper capital and broader capabilities than DarioHealth.
Emerging players
- Headspace Health: Digital mental health platform combining therapy, coaching, and self-guided content. Competes in Dario's behavioral health solution line, primarily focused on mental health versus Dario's multi-condition approach.
- Calm Health: Mental wellness platform with expanding enterprise health offering including therapy, coaching, and self-guided content. Emerging player in the employer behavioral health space overlapping with Dario's anxiety/depression solution.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
DarioHealth social profiles
Digital presenceDarioHealth financial estimates
Financial estimateRevenue estimate
Valuation estimate
DarioHealth leadership team
Management profileNumber of profiles
Profiles18 records
DarioHealth subsidiaries and ownership
Company hierarchySubsidiaries2 records
DarioHealth funding detail
Funding detailFunding overview
Funding rounds22 records
Investors14 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DarioHealth M&A and investment
M&A and investmentM&A4 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DarioHealth
What does DarioHealth do?
DarioHealth operates a multi-condition digital health platform addressing cardiometabolic (diabetes, hypertension, weight management), musculoskeletal, and behavioral health conditions through its mobile app combined with FDA-cleared connected devices (glucometer, blood pressure monitor, scale). The proprietary DarioIQ AI layer provides personalized guidance, biometric interpretation, and engagement optimization, supported by over 13 billion real-world data points and clinical evidence published in peer-reviewed journals.
Is DarioHealth a public or private company?
DarioHealth is a public company. It is classified as public.
When was DarioHealth founded?
DarioHealth was founded in 2011. It employs 101 to 250 people.
Where is DarioHealth based?
DarioHealth is headquartered in New York, United States, in the North America region.
How does DarioHealth make money?
Four revenue lines are on record. B2B Enterprise Sales (Employers & Health Plans) is the primary driver. The others are direct-to-Consumer App & Device Sales, pharma Services & Partnerships and healthcare Cost Savings Studies.
Who are DarioHealth's main competitors?
Direct peers on record are Omada Health, Virta Health, Noom, Hinge Health, Sword Health and Welldoc. Broad incumbents are Livongo (Teladoc Health) and Verily (Alphabet). Emerging players are Headspace Health and Calm Health.
Does DarioHealth have an API?
No public API is recorded for DarioHealth.
What industry is DarioHealth in?
DarioHealth's product category is Digital Therapeutics. Its primary akta.pro industry code is HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity). Its NAICS code is 812191 and its SIC code is 3841.